Regulation Of Chinese Medicine Research Articles

Progress in TLR4/NF-κB Pathway Regulation by Traditional Chinese Medicine for the Treatment of Polycystic Ovary Syndrome

Polycystic ovary syndrome (PCOS) is a common reproductive endocrine disease in women, affecting women's fertility and cardiovascular system. Due to the complexity of its pathogenesis, there are many adverse reactions commonly used in clinical treatment, and the therapeutic effect is short-lived and temporary. TLR4/NF-κB pathway is a classical signaling pathway related to inflammation, and the effective components of TCM compounds and TCM monomers have been proven to reduce the levels of various inflammatory factors in patients by regulating the TLR4/NF-κB pathway, so as to achieve the effect of PCOS. The potential value of TCM in prevention and treatment of PCOS based on TLR4/NF-κB pathway was revealed. This article aims to summarize the recent studies on the improvement of PCOS symptoms by regulating the expression of TLR4/NF-κB pathway by Chinese medicine, so as to further study the mechanism of PCOS prevention and treatment by this pathway under the regulation of Chinese medicine, so as to open up new ideas for the development of new drugs targeting this pathway and clinical research.

Regulation of Chinese medicine in Poland

Regulation of Chinese medicine in Poland

The regulation of Chinese medicine in Thailand

The regulation of Chinese medicine in Thailand

The regulation of Chinese medicine in China

The regulation of Chinese medicine in China

The regulation of Chinese medicine in Spain

The regulation of Chinese medicine in Spain

The regulation of Chinese Medicine in the U.S.

: This study surveys the topic of regulation and reality of studies, the professional practice of Chinese Medicine (CM), the regulation and reality of Chinese phytotherapy, and the level of acceptance by the population in the U.S. The study refers to CM as Acupuncture and Traditional Medicine (AcuTM) to reflect the history and the development of the medicine in the U.S. While the origin of the practice of acupuncture in the U.S. may go back as far as the 1800s, the establishment of AcuTM in the U.S. has been defined by the 1971 article published in 1971 in The New York Times detailing the acupuncture treatment the columnist and journalist, James Reston, received in China. Nevertheless, acupuncture as a profession has only recently been recognized at a federal level in 2018, and quantitative and qualitative studies at a national level are lacking and/or more than a decade old. The information available in individual state and federal regulatory agencies was consulted as much as possible to obtain the most recent information. The singular theme that emerged in this study is changes and transformations of the profession in the U.S. due to its historical development in individual states impacting and affecting national regulations, which in turn, affect individual states as well as the study and the practice of the profession.

Exploring Regulation of Chinese Medicine on Osteoclasts Based on OPG/RANKL/RANK Signaling Pathway

Exploring Regulation of Chinese Medicine on Osteoclasts Based on OPG/RANKL/RANK Signaling Pathway